Current treatments and future potential of surufatinib in neuroendocrine tumors (NETs)

Neuroendocrine tumors (NETs) are rare, heterogeneous, often indolent tumors that predominantly originate in the lungs and gastrointestinal tract. An understanding of the biology and tumor microenvironment of NETs has led to the development of molecularly targeted treatment options including somatost...

Descripción completa

Detalles Bibliográficos
Autor principal: Xu, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411625/
https://www.ncbi.nlm.nih.gov/pubmed/34484432
http://dx.doi.org/10.1177/17588359211042689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411625/
https://www.ncbi.nlm.nih.gov/pubmed/34484432
http://dx.doi.org/10.1177/17588359211042689

Ejemplares similares